McKesson to Buy Pharmacy Tech Firm Rx Savings

Drug distributor McKesson Corporation (NYSE: MCK) will buy private pharmaceutical technology firm Rx Savings Solutions for up to $875 million.

They help employers and health insurers find the most reasonable price for prescription meds. 

Along with that, they also help by providing reminders to continue taking medications as they should.

When speaking of the company's new partnership, McKesson CEO Brian Tyler said that "Rx Savings Solutions' offerings for employers. 

And patients will strengthen McKesson's ability to help solve the most common medication challenges related to access, affordability and adherence."

The planned transaction includes $600 million upfront and up to $275 in payments contingent on Rx Savings.' 

Performance is expected to close in the second half of the fiscal year 2023.